Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
AbbVie Inc. - SIC # 2840 -
Ticker
Exchange
SIC #
Website
Latest Ticker
ABBV
New York
2840
www.abbvie.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for AbbVie Inc.
Why Is AbbVie Inc. (ABBV) Among the Best Large-Cap Value Stocks to Buy in 2025?
- Jan 22nd, 2025 7:58 pm
Is AbbVie Inc. (ABBV) the Best Stock to Invest In For Steady Dividends?
- Jan 22nd, 2025 6:44 pm
Downside risk from talc lawsuit, Stelara generic competition is 'manageable': JNJ CFO Joe Wolk
- Jan 22nd, 2025 5:03 pm
AbbVie Insiders Sold US$56m Of Shares Suggesting Hesitancy
- Jan 22nd, 2025 1:00 pm
Got $1,500? 3 Healthcare Stocks to Buy and Hold Forever
- Jan 21st, 2025 11:22 pm
Evolus, An AbbVie And Botox Rival, Just Hit The Stratosphere — Here's Why
- Jan 21st, 2025 9:04 pm
Got $500? 2 Pharmaceutical Stocks to Buy and Hold Forever
- Jan 21st, 2025 12:10 pm
3 Unstoppable Dividend-Growth Stocks Yielding More Than 3% That Income-Seeking Investors Want to Buy in 2025 and Hold Forever
- Jan 21st, 2025 9:17 am
AbbVie Inc. (ABBV): A Bull Case Theory
- Jan 20th, 2025 12:50 pm
Top Wall Street Analyst Says Dump The Magnificent 7 And Go All In On These Three Big Pharma Dividend Stocks
- Jan 19th, 2025 5:01 pm
Count on Dividend King Pepsi (PEP) for Stability in a Volatile Market
- Jan 18th, 2025 10:01 pm
Why Is AbbVie Inc. (ABBV) Among Louis Navellier’s Top Long-term Stock Picks?
- Jan 18th, 2025 4:21 pm
Ozempic, Xtandi among next 15 drugs selected for U.S. price talks
- Jan 18th, 2025 1:20 pm
Pharma Stock Roundup: J&J's ITCI Buyout, LLY's Weak Q4 Sales
- Jan 17th, 2025 8:00 pm
Popular Ozempic, Wegovy Selected For Next Round Of Medicare Drug Price Negotiations
- Jan 17th, 2025 5:15 pm
Novo Nordisk's stock down 4% as the Feds get ready for a second round of drug price negotiations
- Jan 17th, 2025 2:46 pm
Why the Market Dipped But AbbVie (ABBV) Gained Today
- Jan 16th, 2025 10:45 pm
Humira Holds Firm at 72% Market Share-AbbVie Fends Off Biosimilar Surge
- Jan 16th, 2025 4:41 pm
The Zacks Analyst Blog Highlights Visa, AbbVie, Analog Devices and Precipio
- Jan 16th, 2025 9:30 am
JPM25: The FDA’s future, AbbVie’s second thoughts and Lilly’s lesson
- Jan 16th, 2025 8:56 am
Scroll